ATE69505T1 - In vitro-pruefverfahren zur bestimmung von augenschaedlichen eigenschaften. - Google Patents

In vitro-pruefverfahren zur bestimmung von augenschaedlichen eigenschaften.

Info

Publication number
ATE69505T1
ATE69505T1 AT85902400T AT85902400T ATE69505T1 AT E69505 T1 ATE69505 T1 AT E69505T1 AT 85902400 T AT85902400 T AT 85902400T AT 85902400 T AT85902400 T AT 85902400T AT E69505 T1 ATE69505 T1 AT E69505T1
Authority
AT
Austria
Prior art keywords
dangerous
eyes
test method
vitro test
determining properties
Prior art date
Application number
AT85902400T
Other languages
English (en)
Inventor
Hyman C Bergman
James F Godfrey
Virginia C Gordon
Original Assignee
Preventive Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preventive Diagnostics Corp filed Critical Preventive Diagnostics Corp
Application granted granted Critical
Publication of ATE69505T1 publication Critical patent/ATE69505T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Glass Compositions (AREA)
  • Eye Examination Apparatus (AREA)
AT85902400T 1984-05-04 1985-05-06 In vitro-pruefverfahren zur bestimmung von augenschaedlichen eigenschaften. ATE69505T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/607,483 US4613574A (en) 1984-05-04 1984-05-04 In vitro test for ocular toxic properties
EP85902400A EP0180626B1 (de) 1984-05-04 1985-05-06 In vitro-prüfverfahren zur bestimmung von augenschädlichen eigenschaften
PCT/US1985/000833 WO1985005184A1 (en) 1984-05-04 1985-05-06 In vitro test for ocular toxic properties

Publications (1)

Publication Number Publication Date
ATE69505T1 true ATE69505T1 (de) 1991-11-15

Family

ID=24432480

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85902400T ATE69505T1 (de) 1984-05-04 1985-05-06 In vitro-pruefverfahren zur bestimmung von augenschaedlichen eigenschaften.

Country Status (7)

Country Link
US (1) US4613574A (de)
EP (1) EP0180626B1 (de)
JP (1) JPH073417B2 (de)
AT (1) ATE69505T1 (de)
AU (1) AU578570B2 (de)
DE (1) DE3584661D1 (de)
WO (1) WO1985005184A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053340A (en) * 1989-02-24 1991-10-01 National Testing Corporation In vitro test for dermal toxic properties
EP0600087A4 (en) * 1991-08-19 1996-01-31 Shiseido Co Ltd Method and kit of in vitro irritation test.
EP0653063A4 (de) * 1992-07-27 1997-08-27 Invitro International In-vitro-test für hautkorrosive eigenschaften.
DE19606207A1 (de) 1996-02-21 1997-08-28 Univ Duesseldorf H Heine Verfahren zur Bestimmung der Phototoxizität und/oder Photosensibilität von Stoffen oder Stoffgemischen sowie dessen Verwendung
US20110300572A1 (en) * 2010-06-02 2011-12-08 Integrated Botanical Technologies, Llc In vitro method and apparatus for determining efficacy and action mechanisms of a topical composition on various skin color types
US10041922B2 (en) * 2015-03-31 2018-08-07 Stewart Lebrun Biochemistry based ocular toxicity assay

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2770602A (en) * 1951-06-25 1956-11-13 Aloe Company As Method of preparing protein standardized reagents
US3630682A (en) * 1970-04-21 1971-12-28 Corning Glass Works Determination of molecular weights of proteins
US4020005A (en) * 1975-02-24 1977-04-26 Lang John L Gelled reagent materials
DE3019612A1 (de) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisiertes thrombinpraeparat

Also Published As

Publication number Publication date
EP0180626A4 (de) 1989-02-09
EP0180626B1 (de) 1991-11-13
JPH073417B2 (ja) 1995-01-18
DE3584661D1 (de) 1991-12-19
AU578570B2 (en) 1988-10-27
JPS61502074A (ja) 1986-09-18
EP0180626A1 (de) 1986-05-14
US4613574A (en) 1986-09-23
WO1985005184A1 (en) 1985-11-21
AU4355185A (en) 1985-11-28

Similar Documents

Publication Publication Date Title
DE3171293D1 (en) Composite material of de-n-acetylated chitin and fibrous collagen, its production and use
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
ATE16820T1 (de) Testelement zur bestimmung von glukose in hoher konzentration.
GB2148512B (en) Measuring probe for the potentiometric determination of ion concentrations, process for its manufacture and its application
ATE195148T1 (de) Prozess zur rekombinanten herstellung von hiv-2 - proteinen sowie zellen, die hiv-2 - proteine exprimiert
EP0247730A3 (de) Antikörper, ihre Herstellung sowie Verwendung und dieselben enthaltende Produkte
DE3579177D1 (de) Verfahren zur herstellung von werkstoffen mit gegen scherkraefte empfindlichen einlagen.
DE3575783D1 (de) Probestueck zur untersuchung von oberflaechendurchdringungsmitteln mit auflage wechselnder dicke.
ATE69505T1 (de) In vitro-pruefverfahren zur bestimmung von augenschaedlichen eigenschaften.
DD130489A5 (de) Bruehe zur anzeige des vorliegens von candida-hefe und anderen pilzen
ES481817A1 (es) Procedimiento para determinar magnitudes reologicas carac- teristicas de materiales viscosos.
FR2493311B1 (fr) Derives 2,6-c-dimethyltyrosine1-(d-amino-acide)2-(acide e-amino-caproique et acide g-aminobutyrique)5 de la methionine-encephaline, utiles notamment comme analgesiques
BR8301672A (pt) Aparelho e conjunto de medir forcas e processo de regular o aparelho
DE3168203D1 (en) Process for preparation of xanthogen disulphides and their use as molecular-weight regulators in the polymerisation of chloroprene
DE3576569D1 (de) Analytisches element und seine verwendung zur bestimmung von haemoglobin in vollblut.
DE3585049D1 (de) Monoklonale antikoerper.
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
BE881080A (fr) Nouveaux alpha-hydrazono alpha-phenyl acetonitriles leur preparation et leur application comme colorants de dispersion pour la coloration des matieres artificielles ou synthetiques
DE59105781D1 (de) Verfahren zur Aufbereitung von Fasermaterial sowie Verwendung des Verfahrens.
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
FI852970L (fi) Foerfarande foer bevisning av bis-(2-kloretyl)-sulfid eller bis-(2-kloretyl)-imin.
DE3163302D1 (en) Process for the preparation of alpha-benzamido-alpha'-halogen-1,1'-dianthrimides, alpha-benzamido-5' or 8'-halogen-1,1'-dianthrimides and their application as intermediates for vat dyes
ES460382A1 (es) Un procedimiento para la preparacion de un cetal de 4-(1-hi-droxi-1-metil-etil)-3-ciclohexen-1-ona.
JPS56152496A (en) Novel o-side derivative having blood type properties,manufacture thereof and biological application thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties